Gene therapy and nucleic acid therapeutics

• In: 2B - The new medicines in 20 years time and their impact on pharmacy practice on Saturday, 6 October 2012, 09:00-12:00
• At: Amsterdam (the Netherlands) (2012)
• Type: Presentation
• By: POUTON, Colin (Monash University, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia)
• Abstract:

  The term “gene therapy” was conceived in the early 1970s to describe a medical treatment using DNA as the pharmaceutically active agent, the implication being that a gene product (a protein or RNA molecule) is produced in the host after the DNA is delivered to the nucleus of a target cell. “Nucleic acid therapeutics” is a broader term that

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login